Skip to main content

Table 2 Summary of results of salvage treatment (n = 45)

From: Cancer-specific and overall survival in patients with recurrent prostate cancer who underwent salvage extended pelvic lymph node dissection

Follow-up (months), mean (SD)

42.7

(±20.8)

Median PSA-nadir after salvage ePLND, ng/ml (SD)

4.4

± 1.5

N-stage after salvage ePLND

N0 (%)

19

(42.2 %)

N1 (%)

26

(58.7 %)

No. of LNs removed (range)

971

(4–76)

Mean no. of LNs removed per patient (SD)

21.6

(±9)

No. of positive LNs (range)

183

(1–42)

No. of positive LNs per patient (range)

4,1

(1–42)

No. of deaths (%)

7

(15.6 %)

Time to death (months), mean (range)

48.8

5–105

BR after salvage ePLND n (% patients)

31

(68.9 %)

BCRF immediately after salvage ePLND (complete BR) n (% patients)

22

(48.9 %)

BCRF during follow-up n (% patients)

33

(73.3 %)

Mean BCRF duration (months) (SD)

31.4

(±19.7)

ADT before salvage ePLND

No. (%) patients

36

(80.0 %)

ADT after salvage ePLND

No. (%) patients

40

(88.9 %)

Bone metastases in follow-up after salvage ePLND

No. (%) patients

10

(22.2 %)